Inhibrx Biosciences, Inc. Common Stock

INBXNASDAQUSD
63.72 USD
0.19 (0.30%)AT CLOSE (11:59 AM EDT)
63.48
0.07 (0.11%)
POST MARKET (AS OF 04:14 PM EDT)
Post Market
AS OF 04:14 PM EDT
63.48
0.07 (0.11%)
🟢Market: OPEN
Open?$63.72
High?$66.00
Low?$62.26
Prev. Close?$63.53
Volume?147.6K
Avg. Volume?206.7K
VWAP?$64.38
Rel. Volume?0.71x
Bid / Ask
Bid?$55.47 × 100
Ask?$73.16 × 100
Spread?$17.69
Midpoint?$64.32
Valuation & Ratios
Market Cap?928.0M
Shares Out?14.6M
Float?7.7M
Float %?53.0%
P/E Ratio?N/A
P/B Ratio?116.10
EPS?-$9.59
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.93Strong
Quick Ratio?3.93Strong
Cash Ratio?3.68Strong
Debt/Equity?12.58High
ValuationRICHLY VALUED
Score
50/100
P/E?
N/A
P/B?
116.10HIGH
P/S?
713.83HIGH
P/FCF?
N/A
EV/EBITDA?
-6.8CHEAP
EV/Sales?
695.63HIGH
Returns & Efficiency
ROE?
-1,752.2%WEAK
ROA?
-95.6%WEAK
Cash Flow & Enterprise
FCF?$-129825000
Enterprise Value?$904.3M
Related Companies
Loading...
News
Profile
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Employees
110
Market Cap
928.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2024-05-28
Address
11025 N. TORREY PINES ROAD, SUITE 140
LA JOLLA, CA 92037
Phone: (858) 795-4220